Farther Finance Advisors, LLC Selecta Biosciences Inc Transaction History

Farther Finance Advisors, LLC

  • $2.67 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$0.62 - $0.85 $334 - $458
-539 Closed
0 $0
Q4 2023

Feb 14, 2024
BUY
$0.67 - $1.35 $361 - $727
539 Added 100.0%
1,078 $372,000
Q1 2023

May 13, 2024
SELL
$1.15 - $1.89 $619 - $1,018
-539 Reduced 50.0%
539 $749,000
Q4 2022

Sep 11, 2023
BUY
$0.96 - $1.6 $517 - $862
539 New
539 $609,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email